Mitochondrial quality control in non-exudative age-related macular degeneration: From molecular mechanisms to structural and functional recovery
- PMID: 38579938
- DOI: 10.1016/j.freeradbiomed.2024.03.024
Mitochondrial quality control in non-exudative age-related macular degeneration: From molecular mechanisms to structural and functional recovery
Abstract
Non-exudative age-related macular degeneration (NE-AMD) is the leading blindness cause in the elderly. Clinical and experimental evidence supports that early alterations in macular retinal pigment epithelium (RPE) mitochondria play a key role in NE-AMD-induced damage. Mitochondrial dynamics (biogenesis, fusion, fission, and mitophagy), which is under the central control of AMP-activated kinase (AMPK), in turn, determines mitochondrial quality. We have developed a NE-AMD model in C57BL/6J mice induced by unilateral superior cervical ganglionectomy (SCGx), which progressively reproduces the disease hallmarks circumscribed to the temporal region of the RPE/outer retina that exhibits several characteristics of the human macula. In this work we have studied RPE mitochondrial structure, dynamics, function, and AMPK role on these parameters' regulation at the nasal and temporal RPE from control eyes and at an early stage of experimental NE-AMD (i.e., 4 weeks post-SCGx). Although RPE mitochondrial mass was preserved, their function, which was higher at the temporal than at the nasal RPE in control eyes, was significantly decreased at 4 weeks post-SCGx at the same region. Mitochondria were bigger, more elongated, and with denser cristae at the temporal RPE from control eyes. Exclusively at the temporal RPE, SCGx severely affected mitochondrial morphology and dynamics, together with the levels of phosphorylated AMPK (p-AMPK). AMPK activation with metformin restored RPE p-AMPK levels, and mitochondrial dynamics, structure, and function at 4 weeks post-SCGx, as well as visual function and RPE/outer retina structure at 10 weeks post-SCGx. These results demonstrate a key role of the temporal RPE mitochondrial homeostasis as an early target for NE-AMD-induced damage, and that pharmacological AMPK activation could preserve mitochondrial morphology, dynamics, and function, and, consequently, avoid the functional and structural damage induced by NE-AMD.
Keywords: AMPK; Metformin; Mitochondria dynamics; Non-exudative age-related macular degeneration; Retinal pigment epithelium.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors have declared that no conflict of interest exists.
Similar articles
-
Oxidative stress damage circumscribed to the central temporal retinal pigment epithelium in early experimental non-exudative age-related macular degeneration.Free Radic Biol Med. 2019 Feb 1;131:72-80. doi: 10.1016/j.freeradbiomed.2018.11.035. Epub 2018 Nov 28. Free Radic Biol Med. 2019. PMID: 30502459
-
Enriched environment and visual stimuli protect the retinal pigment epithelium and photoreceptors in a mouse model of non-exudative age-related macular degeneration.Cell Death Dis. 2021 Dec 4;12(12):1128. doi: 10.1038/s41419-021-04412-1. Cell Death Dis. 2021. PMID: 34864827 Free PMC article.
-
Melatonin protects the retina from experimental nonexudative age-related macular degeneration in mice.J Pineal Res. 2020 May;68(4):e12643. doi: 10.1111/jpi.12643. Epub 2020 Mar 13. J Pineal Res. 2020. PMID: 32133696
-
Mitochondria: Potential Targets for Protection in Age-Related Macular Degeneration.Adv Exp Med Biol. 2018;1074:11-17. doi: 10.1007/978-3-319-75402-4_2. Adv Exp Med Biol. 2018. PMID: 29721922 Review.
-
PGC-1α Protects RPE Cells of the Aging Retina against Oxidative Stress-Induced Degeneration through the Regulation of Senescence and Mitochondrial Quality Control. The Significance for AMD Pathogenesis.Int J Mol Sci. 2018 Aug 7;19(8):2317. doi: 10.3390/ijms19082317. Int J Mol Sci. 2018. PMID: 30087287 Free PMC article. Review.
Cited by
-
Artemisinin and Its Derivatives: Promising Therapeutic Agents for Age-Related Macular Degeneration.Pharmaceuticals (Basel). 2025 Apr 6;18(4):535. doi: 10.3390/ph18040535. Pharmaceuticals (Basel). 2025. PMID: 40283970 Free PMC article. Review.
-
Co-delivery of antioxidants and siRNA-VEGF: promising treatment for age-related macular degeneration.Drug Deliv Transl Res. 2025 Jul;15(7):2272-2300. doi: 10.1007/s13346-024-01772-x. Epub 2025 Jan 3. Drug Deliv Transl Res. 2025. PMID: 39751765 Review.
-
Revolutionary drug repositioning: the preventive and therapeutic potential of metformin and other antidiabetic drugs in age-related macular degeneration.Front Pharmacol. 2024 Dec 10;15:1507860. doi: 10.3389/fphar.2024.1507860. eCollection 2024. Front Pharmacol. 2024. PMID: 39720591 Free PMC article.
-
Ferroptosis: a novel mechanism of cell death in ophthalmic conditions.Front Immunol. 2024 Jun 27;15:1440309. doi: 10.3389/fimmu.2024.1440309. eCollection 2024. Front Immunol. 2024. PMID: 38994366 Free PMC article. Review.
-
Targeting caspase-8: a new strategy for combating hepatocellular carcinoma.Front Immunol. 2024 Dec 12;15:1501659. doi: 10.3389/fimmu.2024.1501659. eCollection 2024. Front Immunol. 2024. PMID: 39726605 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical